MedPath

Preterm Birth Prevention Study - Treating vaginal infections to prevent prematurity

Phase 3
Suspended
Conditions
Preterm birth
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Registration Number
ACTRN12617001593325
Lead Sponsor
niversity of Western Australia
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Female
Target Recruitment
6174
Inclusion Criteria

Singleton pregnancy and ultrasound-confirmed gestation.

Exclusion Criteria

Multiple pregnancies, symptomatic vaginal infections, vaginal bleeding, rupture of membranes, active contractions, antimicrobial therapy within 14 days prior to recruitment.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Spontaneous preterm birth rate <37 weeks in the intervention vs control group, as assessed by review of delivery outcome data obtained with consent from local hospital databases.[ <37 weeks gestation.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath